Hippo Holdings Inc. filings document formal disclosures for a NYSE-listed insurance technology company with common stock trading under HIPO. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentations, supplemental financial information, and reconciliations of non-GAAP measures to GAAP measures.
The company’s proxy filings cover annual meeting materials, stockholder voting matters, board governance, and public-company disclosure requirements. Together, the filing record emphasizes Hippo’s insurance-platform performance, premium and underwriting metrics, capital and equity disclosures, and governance framework.
Hippo Holdings Inc. (HIPO) officer Guy Zeltser reported a planned sale of 1,669 common shares, with an aggregate market value of $48,651.35 and an approximate sale date of July 28, 2026. He acquired the shares from the issuer as restricted stock units on February 15, 2026. Morgan Stanley Smith Barney LLC is named as broker. The plan-adoption or instruction date listed, if relying on Rule 10b5-1, is June 18, 2025.
Hippo Holdings Inc. Chief Executive Officer Richard McCathron reported an open-market sale of 5,000 shares of common stock on July 9, 2026 at $28.53 per share. According to the filing, the sale was effected under a Rule 10b5-1 trading plan dated August 29, 2025. Following the transaction, he directly holds 585,433 shares, which include 296,227 RSUs.
Hippo Holdings Inc. (HIPO) officer Richard McCathron reported a proposed sale of 5,000 common shares, with an aggregate market value of $142,650 and an approximate sale date of July 9, 2026. Merrill Lynch is listed as the broker, and the notice lists a Rule 10b5-1 plan adoption date of August 29, 2025. It also lists three earlier sales of 5,000 shares each: April 9, May 11 and June 9, 2026, for gross proceeds of $130,250, $135,500 and $125,000, respectively.
Hippo Holdings Inc. appointed Laura Boettcher as Chief Operating Officer. She previously served as COO of subsidiary Hippo Analytics Inc., and earlier held roles including Chief of Staff to the CEO and Director of Reinsurance, bringing substantial insurance and reinsurance experience.
In her new role, Boettcher’s base salary was set at $450,000, with an annual target bonus equal to 50% of base salary. Her annual restricted stock unit grant value was increased to $660,000, and her annual performance restricted stock unit grant value to $440,000, including a bridge equity grant to align 2026 awards.
Boettcher Laura reported acquisition or exercise transactions in this Form 4 filing.
Hippo Holdings Inc. reported that Chief Operating Officer Laura Boettcher received a grant of 11,674 shares of Common Stock on June 10, 2026 at a price of $0.00 per share, reflecting stock-based compensation rather than an open-market purchase.
After this award, Boettcher directly holds 72,967 shares of Hippo common stock, which the filing notes include 43,749 restricted stock units (RSUs). She also indirectly owns 60 shares held by her spouse. The filing does not show any open-market buying or selling; it records a compensation-related equity grant and updated ownership totals.
Hippo Holdings Inc. executive Laura Boettcher, the Chief Operating Officer, filed an initial Form 3 reporting her ownership of the company’s common stock. The filing shows beneficial ownership of 29,218 shares held directly and 60 shares held indirectly.
The 60 indirectly held shares are owned by the reporting person’s spouse, as noted in the footnote. The Form 3 does not reflect any new purchase or sale activity; it simply establishes Boettcher’s existing equity position as she becomes a reporting insider.
Hippo Holdings Inc. Chief Executive Officer Richard McCathron sold 5,000 shares of common stock at $25.00 per share in an open-market transaction. The sale was made pursuant to a pre-arranged Rule 10b5-1 trading plan dated August 29, 2025. Following this sale, he directly holds 590,433 shares, which include 296,227 restricted stock units (RSUs).
Hippo Holdings Inc. (HIPO) officer Richard McCathron reported a proposed sale of 5,000 common shares, with an aggregate market value of $125,000 and an approximate sale date of June 9, 2026. The shares were acquired as restricted stock units on December 24, 2020. The listed Rule 10b5-1 plan adoption or instruction date is August 29, 2025. During the prior three months, McCathron reported sales of 5,000 shares each on March 9, April 9 and May 11, 2026, with gross proceeds of $129,300, $130,250 and $135,500, respectively.
Ellis Stewart reported acquisition or exercise transactions in this Form 4 filing.
Hippo Holdings Inc. director Ellis Stewart received an equity grant in the form of restricted stock units (RSUs). He was awarded 4,820 RSUs, each convertible into one share of common stock upon vesting. The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting, provided he continues serving the company and its subsidiaries through that date.
Following this award, Stewart holds 121,105 shares of common stock directly and 10,335 shares indirectly through Preservation Trust Company, Inc., as trustee of the Desertfish Nevada Trust. The grant was recorded at a price of $0.00 per share, reflecting its nature as compensation rather than a market purchase.
Hippo Holdings Inc. director Ellis Stewart reported his initial ownership in the company’s common stock. The filing shows 10,335 shares held indirectly through Preservation Trust Company, Inc., as trustee of the Desertfish Nevada Trust, and 116,285 shares held directly in his name.